|
VANGL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.252800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.159600E-01 |
| Normal-vs-Stage2 |
1.316040E-01 |
| Normal-vs-Stage3 |
3.465800E-01 |
| Normal-vs-Stage4 |
3.344100E-02 |
| Stage1-vs-Stage2 |
2.887600E-01 |
| Stage1-vs-Stage3 |
6.402800E-01 |
| Stage1-vs-Stage4 |
8.666300E-02 |
| Stage2-vs-Stage3 |
5.067000E-01 |
| Stage2-vs-Stage4 |
5.900600E-01 |
| Stage3-vs-Stage4 |
2.074400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.889600E-01 |
| Normal-vs-AfricanAmerican |
8.004000E-01 |
| Normal-vs-Asian |
5.693800E-01 |
| Caucasian-vs-AfricanAmerican |
9.295200E-01 |
| Caucasian-vs-Asian |
9.397600E-01 |
| AfricanAmerican-vs-Asian |
8.997000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.236000E-01 |
| Normal-vs-Female |
1.826580E-01 |
| Male-vs-Female |
5.265200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.948800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.665200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.410500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.156000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.432400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.759780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.927830E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.070400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.033960E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.574970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.403800E-04 |
| Classical-VS-Follicular |
3.43030000005129E-06 |
| Classical-VS-Other |
6.558600E-01 |
| Classical-VS-Normal |
8.199400E-01 |
| Tall-VS-Follicular |
6.262000E-01 |
| Tall-VS-Other |
2.853600E-01 |
| Tall-VS-Normal |
9.543800E-03 |
| Follicular-VS-Other |
2.428200E-01 |
| Follicular-VS-Normal |
1.157240E-03 |
| Other-VS-Normal |
6.308200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.798230E-01 |
| Normal-vs-N1 |
7.225700E-02 |
| N0-vs-N1 |
4.648800E-01 |
|
|
